Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial
Titel:
Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial
Auteur:
Sarraju, Ashish Li, JingWei Cannon, Christopher P. Chang, Tara I. Agarwal, Rajiv Bakris, George Charytan, David M. de Zeeuw, Dick Greene, Tom Heerspink, Hiddo J.L. Levin, Adeera Neal, Bruce Pollock, Carol Wheeler, David C. Yavin, Yshai Zhang, Hong Zinman, Bernard Perkovic, Vlado Jardine, Meg Mahaffey, Kenneth W.